Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS

By sjmartinez • May 20, 2025

Kim NH, Chin KM, McLaughlin VV, Ong R, MacDonald G, Martin N, Senatore A, Channick R. Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS. Adv Ther. 2025 May 19. doi: 10.1007/s12325-025-03180-0. Epub ahead of print. PMID: 40388087.

Tags: Cardiovascular comorbidities, combination therapy, Hospitalization, Macitentan, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, real-world data, safety, survival, Tadalafil

Median Survival Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction Prescribed Quadruple Medical Therapy

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Butler J, Fonarow GC. Median Survival Among Patients Hospitalized[...]

Adult congenital cardiac interventional training, competencies, and organization. A Statement of the ESC ACHD Working Group, the EAPCI, the AEPC, and the PICS-Society

Chessa M, Brida M, Budts W, Chieffo A, Dua J, Kaleschke G, Kempny A, Kenny D, Krasemann T, Rahbek Schmidt M, Aboulhosn J. Adult congenital[...]

Rapid Cas13a-based pen A genotyping for cefixime susceptibility in Neisseria gonorrhoeae

Nguyen THY, Garg S, Adams G, Mantena S, Gopal N, Suk H-J, D Klausner J, Sabeti PC, Lemieux JE, Allan-Blitz L-T. Rapid Cas13a-based penA genotyping for[...]